| 000 | 01547 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514192443.0 | ||
| 264 | 0 | _c20040927 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0300-0664 | ||
| 024 | 7 |
_a10.1111/j.1365-2265.2004.02077.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaïeb, D | |
| 245 | 0 | 0 |
_aDoes iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma? _h[electronic resource] |
| 260 |
_bClinical endocrinology _cJul 2004 |
||
| 300 |
_a102-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _a3-Iodobenzylguanidine |
| 650 | 0 | 4 |
_aAdrenal Gland Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetanephrine _xurine |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPheochromocytoma _xdiagnostic imaging |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 700 | 1 | _aSebag, F | |
| 700 | 1 | _aHubbard, J G | |
| 700 | 1 | _aMundler, O | |
| 700 | 1 | _aHenry, J F | |
| 700 | 1 | _aConte-Devolx, B | |
| 773 | 0 |
_tClinical endocrinology _gvol. 61 _gno. 1 _gp. 102-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2265.2004.02077.x _zAvailable from publisher's website |
| 999 |
_c14917961 _d14917961 |
||